Drugplain

M-END DMX .667 mg/5mL

Dexbrompheniramine Maleate, Dextromethorphan Hydrobromide, Pseudoephedrine Hydrochloride · LIQUID · R. A. McNeil Company

No Recall History
Plain English

M-END DMX is a liquid containing dexbrompheniramine maleate, dextromethorphan hydrobromide, pseudoephedrine hydrochloride at .667 mg/5mL, taken oral. Manufactured by R. A. McNeil Company.

Key Facts

Brand Name
M-END DMX
Generic Name
Dexbrompheniramine Maleate, Dextromethorphan Hydrobromide, Pseudoephedrine Hydrochloride
NDC Code (Product)
12830-816
Manufacturer
R. A. McNeil Company
Strength
.667 mg/5mL
Dosage Form
LIQUID
Route
ORAL
Marketing Status
Application #
M012
Marketing Start
10/13/2011

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

abdominal pain1 reports
abdominal pain lower1 reports
abdominal pain upper1 reports
adenoidal hypertrophy1 reports
anxiety1 reports
arthralgia1 reports
attention deficit/hyperactivity disorder1 reports
autism1 reports
aversion1 reports
biliary dyskinesia1 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

Uses temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies: runny nose sneezing itching of the nose or throat itchy, watery eyes cough due to minor throat and bronchial irritation nasal congestion reduces swelling of nasal passages

Dosage & Administration

Directions Do not exceed 4 doses in a 24 hour period. Adults and children 12 years of age and over: 3 teaspoonfuls (15 mL) every 6 hours, not to exceed 12 teaspoonfuls in 24 hours Children 6 to under 12 years of age: 1 1/2 teaspoonfuls (7.5 mL) every 6 hours, not to exceed 6 teaspoonfuls in 24 hours Children under 6 years of age: Consult a Physician.

Warnings

Warnings Do not exceed recommended dosage. Do not use this product if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product Ask a doctor before use if you have a breathing problem such as emphysema or chronic bronchitis glaucoma trouble urinating due to an enlarged prostate gland a cough that lasts or is chronic such as occurs with smoking, asthma or emphysema a cough that occurs with too much phlegm (mucus) heart disease high blood pressure thyroid disease diabetes Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers. When using this product excitability may occur, especially in children may cause marked drowsiness avoid alcoholic drinks alcohol, sedatives, and tranquilizes may increase the drowsiness effect be careful when driving a motor vehicle or operating machinery Stop use and ask a doctor if cough or nasal congestion persists for more than 1 week, tends to recur, or is accompani

Frequently Asked Questions

What is M-END DMX used for?

M-END DMX contains Dexbrompheniramine Maleate, Dextromethorphan Hydrobromide, Pseudoephedrine Hydrochloride. It is a liquid taken oral. Consult your doctor for specific uses.

Is M-END DMX a controlled substance?

M-END DMX is not classified as a controlled substance by the DEA.

What is the generic name for M-END DMX?

The generic name for M-END DMX is Dexbrompheniramine Maleate, Dextromethorphan Hydrobromide, Pseudoephedrine Hydrochloride. There are no other listed brand versions of Dexbrompheniramine Maleate, Dextromethorphan Hydrobromide, Pseudoephedrine Hydrochloride.

What is the NDC code for M-END DMX .667 mg/5mL?

The NDC (National Drug Code) for M-END DMX .667 mg/5mL is 12830-816, listed by R. A. McNeil Company.

Product NDC

12830-816

Package NDC

12830-816-16

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)